Hans Peterse

3.1k total citations · 1 hit paper
11 papers, 2.3k citations indexed

About

Hans Peterse is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Hans Peterse has authored 11 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Hans Peterse's work include Breast Cancer Treatment Studies (6 papers), Metastasis and carcinoma case studies (2 papers) and Cancer Genomics and Diagnostics (2 papers). Hans Peterse is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Metastasis and carcinoma case studies (2 papers) and Cancer Genomics and Diagnostics (2 papers). Hans Peterse collaborates with scholars based in Netherlands, United States and United Kingdom. Hans Peterse's co-authors include Marc J. van de Vijver, Dimitry S.A. Nuyten, Stephen B. Fox, Adrian L. Harris, Pierre Farmer, Christos Sotiriou, Martine Piccart, Benjamin Haibe‐Kains, Fátima Cardoso and Sherene Loi and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Hans Peterse

10 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

2006 1.5k citations Christos Sotiriou, Pratyaksha Wirapati et al. JNCI Journal of the National Cancer Institute profile →

Peers

Countries citing papers authored by Hans Peterse

Since Specialization

Citations

This map shows the geographic impact of Hans Peterse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Peterse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Peterse more than expected).

Fields of papers citing papers by Hans Peterse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Peterse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Peterse. The network helps show where Hans Peterse may publish in the future.

Co-authorship network of co-authors of Hans Peterse

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Peterse. A scholar is included among the top collaborators of Hans Peterse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Peterse. Hans Peterse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Gene Expression Profiles of Primary Breast Carcinomas from Patients at High Risk for Local Recurrence after Breast-Conserving Therapy 2006 ·Clinical Cancer Research ·Bas Kreike, Hans Halfwerk, Petra Kristel, Annuska M. Glas, Hans Peterse, Harry Bartelink, Marc J. van de Vijver	44
2	Predicting a local recurrence after breast-conserving therapy by gene expression profiling 2006 ·Breast Cancer Research ·Dimitry S.A. Nuyten, Bas Kreike, Augustinus A. M. Hart, Jen‐Tsan Chi, Julie B. Sneddon, Lodewyk F.A. Wessels, Hans Peterse, Harry Bartelink, Patrick O. Brown, Howard Y. Chang, Marc J. van de Vijver	143
3	Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis breakdown → 2006 ·JNCI Journal of the National Cancer Institute ·Christos Sotiriou, Pratyaksha Wirapati, Sherene Loi, Adrian L. Harris, Stephen B. Fox, Johanna Smeds, Hans Nordgren, Pierre Farmer, Viviane Praz, Benjamin Haibe‐Kains, Christine Desmedt, Denis Larsimont, Fátima Cardoso, Hans Peterse, Dimitry S.A. Nuyten, Marc Buyse, Marc J. van de Vijver, Jonas Bergh, Martine Piccart, Mauro Delorenzi	1525
4	Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer 2006 ·European Journal of Cancer Supplements ·Mieke Kriege, (unknown), C. Boetes, Hans Peterse, R.A.E.M. Tollenaar, Jan C. Oosterwijk, R. A. Manoliu, Harry J. de Koning, Emiel J. Rutgers, J.G.M. Klijn	0
5	p27kip1 expression in breast carcinomas: An immunohistochemical study on 512 patients with long-term follow-up 2000 ·International Journal of Cancer ·Mattia Barbareschi, Harm van Tinteren, Francesco Mauri, Silvio Veronese, Hans Peterse, Patrick Maisonneuve, Orazio Caffo, (unknown), Claudio Doglioni, Enzo Galligioni, Paolo Palma, Rob Michalides	58
6	Clinical presentation, endoscopic features, and treatment of gastric metastases from breast carcinoma 2000 ·Cancer ·Babs G. Taal, Hans Peterse, Henk Boot	139
7	Clinical presentation, endoscopic features, and treatment of gastric metastases from breast carcinoma 2000 ·Cancer ·Babs G. Taal, Hans Peterse, Henk Boot	25
8	Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence 1995 ·European Journal of Cancer ·(unknown), Jacques Borger, A. A. M. Hart, Hans Peterse, Harry Bartelink, (unknown)	65
9	Risk factors in breast-conservation therapy. 1994 ·Journal of Clinical Oncology ·Jacques Borger, (unknown), A.A.M. Hart, Hans Peterse, Jacques J. M. van Dongen, Harry Bartelink	220
10	Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations 1994 ·Cancer Genetics and Cytogenetics ·R.S. Cornelis, M. van Vliet, Catharina M.P. Vos, A.M. Cleton-Jansen, Marc J. van de Vijver, Hans Peterse, P. Meera Khan, (unknown), C.J. Cornelisse, Peter Devilee	28
11	Prognostic value of morphometry and DNA flow‐cytometry features of invasive breast cancers detected by population screening: Comparison with control group of hospital patients 1991 ·International Journal of Cancer ·Anne M. Uyterlinde, Jan P. A. Baak, N W Schipper, Hans Peterse, Jos W. R. Meijer, (unknown), (unknown)	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact